XML 92 R76.htm IDEA: XBRL DOCUMENT v3.3.1.900
Equity Incentive Program - Stock Options and SSARs (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
SSARs, Number of Shares (in shares):      
Forfeited (13,380)    
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Dividend yield 0.00%    
Expected life (years) 4 years 6 months    
SSARs, Weighted-average grant date fair value (in dollars per share):      
Granted $ 18.00    
Stock Options, Number of Shares (in share):      
Beginning balance 1,327,990    
Granted 1,980,959    
Assumed from Audience Acquisition 29,117    
Exercised (2,100)    
Forfeited (162,069)    
Expired (8,341)    
Ending balance 3,165,556 1,327,990  
Exercisable 217,506    
Stock Options, Weighted Average Exercise Price (in dollars per share):      
Beginning balance $ 29.31    
Granted 18.00    
Assumed from Audience Acquisition 17.50    
Exercised 12.65    
Forfeited 20.67    
Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 28.83    
Ending balance 22.58 $ 29.31  
Exercisable $ 29.19    
SARS and Options, Additional Disclosures      
Options, aggregate intrinsic value, outstanding $ 0.0    
Options, aggregate intrinsic value, exercisable $ 0.0    
Options, weighted average remaining contractual term, outstanding 6 years    
Options, weighted average remaining contractual term, exercisable 5 years 4 months    
Unrecognized compensation expense $ 16.9    
Weighted average period for compensation expense to be recognized 1 year 6 months    
SSARs and Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate     1.39%
Dividend yield   0.00% 2.06%
Expected life (years)     7 years 1 month 6 days
Volatility     33.80%
Fair value at date of grant     $ 20.62
SSARs      
SSARs, Number of Shares (in shares):      
Beginning balance 1,064,383    
Granted 0    
Assumed from Audience Acquisition 0    
Exercised (18,947)    
Expired (18,276)    
Ending balance 1,013,780 1,064,383  
Exercisable 687,897    
SSARs, Weighted-average grant date fair value (in dollars per share):      
Beginning balance $ 20.81    
Granted 0.00    
Assumed from Audience Acquisition 0.00    
Exercised 11.79    
Forfeited 23.92    
Expired 21.89    
Ending balance 20.92 $ 20.81  
Exercisable 19.50    
Stock Options, Weighted Average Exercise Price (in dollars per share):      
Granted $ 0.00    
SARS and Options, Additional Disclosures      
SSARs, aggregate intrinsic value, outstanding $ 0.1    
SSARs, aggregate intrinsic value, exercisable $ 0.1    
SSARs, weighted average remaining contractual terms, outstanding 5 years 10 months    
SSARs, weighted average remaining contractual term, exercisable 5 years 1 month    
Unrecognized compensation expense $ 0.1    
Weighted average period for compensation expense to be recognized 1 month    
Minimum | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate 1.24% 1.32%  
Expected life (years)   4 years 6 months  
Volatility 39.80% 42.90%  
Fair value at date of grant $ 5.94 $ 7.99  
Maximum | Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]      
Risk-free interest rate 1.50% 1.70%  
Expected life (years)   5 years 3 months 29 days  
Volatility 42.40% 49.90%  
Fair value at date of grant $ 6.88 $ 13.50